Jiangsu Hengrui Medicine Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have disclosed Toll-like receptor 7 (TLR7) and/or TLR8 and/or TLR9 antagonists reported to be useful for the treatment of ...
Research published in Nature indicates that persistent signaling downstream of Toll-like receptor (TLR)-7 and TLR9 in plasmacytoid dentritic cells (pDCs) might explain why glucocorticoids are less ...
A denosine deaminase 2 (ADA2) has been identified as a regulator of toll-like receptor 9 (TLR9) activation in response to ...
TLR7 and TLR9 are also thought to be involved in B-cell-mediated production of autoantibodies specific to nucleic acids, thereby triggering and then promoting SLE. Barrat et al. have described ...